BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406 AND Diagnosis
13 results:

  • 1. Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
    Peretz Soroka H; Vora T; Noujaim J; Marcoux N; Cohen-Gogo S; Alcindor T; Holloway C; Rodrigues C; Karachiwala H; Alvi S; Lee U; Cheng S; Banerji S; Oberoi S; Feng X; Smrke A; Simmons C; Razak AA; Gupta AA
    Cancer Med; 2023 Sep; 12(18):18872-18881. PubMed ID: 37724607
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma.
    Mansour MSI; Huseinzade A; Seidal T; Hejny K; Maty A; Taheri-Eilagh F; Mager U; Dejmek A; Dobra K; Brunnström H
    Cytopathology; 2023 Sep; 34(5):456-465. PubMed ID: 37337638
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Characterizing the distribution of alterations in mesothelioma and their correlation to morphology.
    Chen-Yost HI; Tjota MY; Gao G; Mitchell O; Kindler H; Segal J; Husain AN; Mueller J; Schulte JJ
    Am J Clin Pathol; 2023 Sep; 160(3):238-246. PubMed ID: 37141416
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnostic capacity of bap1 and MTAP in cytology from effusions and biopsy in mesothelioma.
    Lynggård LA; Panou V; Szejniuk W; Røe OD; Meristoudis C
    J Am Soc Cytopathol; 2022; 11(6):385-393. PubMed ID: 35945149
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Intracranial angiomatoid fibrous histiocytoma with rhabdoid features: a mimic of rhabdoid meningioma.
    Vizcaino MA; Giannini C; Chang HT; Kipp BR; Fritchie K; Vaubel R
    Brain Tumor Pathol; 2021 Apr; 38(2):138-144. PubMed ID: 33432531
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with bap1.
    Zaleski M; Kalhor N; Fujimoto J; Wistuba I; Moran CA
    Pathol Res Pract; 2020 Dec; 216(12):153267. PubMed ID: 33176261
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.
    Dacic S; Le Stang N; Husain A; Weynand B; Beasley MB; Butnor K; Chapel D; Gibbs A; Klebe S; Lantuejoul S; Roden AC; Roggli V; Tazelaar H; Vignaud JM; Galateau-Sallé F
    Mod Pathol; 2020 Feb; 33(2):255-262. PubMed ID: 31273316
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. diagnosis and characterization of malignant effusions through pleural fluid cytological examination.
    Porcel JM
    Curr Opin Pulm Med; 2019 Jul; 25(4):362-368. PubMed ID: 31082996
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A combination of MTAP and bap1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis.
    Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Sato A; Tsujimura T; Ueda H; Makihata S; Kato F; Iwasaki A; Nabeshima K
    Lung Cancer; 2018 Nov; 125():198-204. PubMed ID: 30429020
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Loss of BRCA associated protein 1 expression in malignant mesothelioma and its diagnostic application].
    Guo ZY; Sun WY; Michele Y; Zhang JL; Hu D; Su HN; Yang WM; Mao W
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):699-703. PubMed ID: 29050072
    [No Abstract]    [Full Text] [Related]  

  • 11. bap1 Immunohistochemistry and p16 FISH in the diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.
    Hwang HC; Pyott S; Rodriguez S; Cindric A; Carr A; Michelsen C; Thompson K; Tse CH; Gown AM; Churg A
    Am J Surg Pathol; 2016 May; 40(5):714-8. PubMed ID: 26900815
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pleural neoplastic pathology.
    Karpathiou G; Stefanou D; Froudarakis ME
    Respir Med; 2015 Aug; 109(8):931-43. PubMed ID: 26048082
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, bap1, aquaporin-1 and microRNA.
    Henderson DW; Reid G; Kao SC; van Zandwijk N; Klebe S
    J Clin Pathol; 2013 Oct; 66(10):854-61. PubMed ID: 23833051
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.